A Belgian spin-off is looking for a device to encapsulate a dose of islets of Langherans before implantation (surgery) into a patient.
Several types of collaboration with preferentially an industrial partner could be established according to the stage of development of the proposed device and its need of adaptation to the objective of the Belgian company.
A start-up from Belgium, spin-off of an university having a strong knowledge in life sciences aiming at valorizing the academic know-how into business, is looking for a device to encapsulate a dose of islets of Langherans (coming from genetically modified pigs) before implantation (surgery) into an individual in order to treat diabetes. The device must protect the islets and allow exchanges of oxygen and insulin. It must be bio compatible and not exceed 16 cm² and 200µm thickness. The goal is to replace insulin injection for the patient by a medical device to last one year.
The technological partner must be GMP compliant and ideally have background into living material encapsulation.
The intellectual property could be shared between the two partners.
The company is looking preferably for a device already on the market or close to, but is also open for collaborating from previous stages by example by adapting a device designed for another purpose.
- Type of partner sought: The device must be bio compatible, the dimensions must not exceed 16 cm² and 200µm thickness, and the process (filling or printing) must be GMP.
- Specific area of activity of the partner: The start-up is looking for an industrial partner to provide the appropriate device, but also to fill it with the islets of Langherans.
Already on the market - GMP (good manufacturing practices) proved system required